Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Randomized Controlled Trial of the Efficacy and Safety of Deferiprone: Subgroup Analysis of Pediatric Patients in Iron-Overloaded Patients with Sickle Cell Disease and Other Anemias

Mona Hamdy, Amal El-Beshlawy, Fatma Soliman Elsayed Ebeid, Janet L. Kwiatkowski, Julie Kanter, Baba PD Inusa, Suzan Williams, David Lee, Noemi T Temin, Caroline Fradette, Fernando Tricta, Mohsen Saleh Elalfy

Blood (2021) 138 (Supplement 1): 762.

https://doi.org/10.1182/blood-2021-148064

Published: 2021

Journal Articles

A Prospective Observational Multicenter Study on Deferiprone & Deferasirox in Clinical Practice of Pediatric Patients with Transfusion-Dependent B-Thalassemia

Mohsen Saleh Elalfy, Amira Adly, Tamer Hassan, Mohamed Maebid, Rasha el Ashry, Khaled Sayeh, S Regab, Amal Elbeshlawy, Mona Hamdy, M Elshanshoury, Omar Elalfy, S Shehata, M EL Hawy, S Abd el Helim, Eman El Askary, N Shahein

Blood (2021) 138 (Supplement 1): 5044.

https://doi.org/10.1182/blood-2021-149462

Published: 2021

Journal Articles

Safety and Efficacy of Early-Start Deferiprone in Infants and Young Children with Beta-Thalassemia (START study)

Mohsen Saleh Elalfy, Amal El-Beshlawy, Amira Adly, Fatma Soliman Elsayed Ebeid, Caroline Fradette, David Lee, Noemi T Temin, Fernando Tricta, Anna Rozova, Mona Hamdy

Blood (2021) 138 (Supplement 1): 3070.

https://doi.org/10.1182/blood-2021-147595

Published: 2021

Journal Articles

A Prospective Randomized Multicenter Trial Using Either Deferiprone or Deferasirox after an Early Start of Deferiprone or Placebo in Young Children Newly Diagnosed with Transfusion-Dependent Beta-Thalassemia

Mohsen Saleh Elalfy, Amira Adly, Fatma Soliman Elsayed Ebeid, Amal El-Beshlawy, Neveen Salama, Mona Hamdy

Blood (2021) 138 (Supplement 1): 3071.

https://doi.org/10.1182/blood-2021-149359

Published: 2021

Journal Articles

Adolescents and Young Adults with Immune Thrombocytopenia (ITP): A Project of the Carmen-France and Parc-ITP Registry

Alexandra Schifferli, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Marc Michel, Nathalie Aladjidi, Guy Leverger, Mohsen Saleh Elalfy, John Grainger, Meera B. Chitlur, Andrea Heiri, Susanne Holzhauer, Thomas Kuehne

Blood (2021) 138 (Supplement 1): 2079.

https://doi.org/10.1182/blood-2021-148488

Published: 2021

Journal Articles

Brain Iron Content in Egyptian Patients with Sickle Cell Disease: Impact on Neurocognitive Functions

Mohsen Saleh Elalfy, MD, Ahmed Smair, MD, Ghada Samir, Hanaa Hussein, Hend Mohammed, Fatma Soliman Elsayed Ebeid, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-139168

Published: 2020

Journal Articles

Randomized Controlled Trial of the Efficacy and Safety of Deferiprone in Iron-Overloaded Patients with Sickle Cell Disease or Other Anemias

Blood (2019) 134 (Supplement_1): 618.

https://doi.org/10.1182/blood-2019-122062

Published: 2019

Journal Articles

Intracranial Hemorrhage in Egyptian Children with Primary Immune Thrombocytopenia (ITP): Report of 24 Cases in 20 Years

Mohsen Saleh Elalfy, MD, Mohamed Ahmed Badr, MD, Ahmed Mansour, MD, Tamer Hassan, MD, Mohamed Meabed, Hoda Hassab, MD, Mahmoud Elhawy, MD, Ilham Youssry, MD, Marwa AbdelHady, MD, Mohamed Elshanshory, MD, Omar Elalfy, MD, Marwa Wahid, MD, Khalid Elsayh, MD

Blood (2019) 134 (Supplement_1): 1080.

https://doi.org/10.1182/blood-2019-122240

Published: 2019

Journal Articles

Pancreatic Iron Deposition Following the Role of Iron Loading Among Transfusion Dependent Sickle Cell Disease Egyptian Children and Young Adults

Mohsen Saleh Elalfy, MD, Khalid Allam, MD, Ahmed Ibrahim, MD, Basant Mosaad, MD, Fatma Soliman Elsayed Ebeid, MD

Blood (2019) 134 (Supplement_1): 4828.

https://doi.org/10.1182/blood-2019-123683

Published: 2019

Journal Articles

Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience

Mohsen Saleh Elalfy, MD, Tamer Hassan, MD, Khalid Elsayh, MD, Mohamed Maebid, MD, Hoda Hassab, MD, Rasha Elashry, MD, Mona El ghamrawy, MD, Mahmoud Elhawy, MD, Marwa Zakaria, MD, Mohamed Elshanshory, MD

Blood (2019) 134 (Supplement_1): 4907.

https://doi.org/10.1182/blood-2019-121994

Published: 2019

Journal Articles

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

Flora Peyvandi, MD PhD, Paolo Bucciarelli, MD, Carla Valsecchi, BSc, Marco Boscarino, Roberta Palla, PhD, Elena Santagostino, Amal El-Beshlawy, Mohsen Saleh Elalfy, MD, Vijay M. Ramanan, MBBS,MDDM, Peyman Eshghi, MD, Suresh Hanagavadi, MD, Mehran Karimi, MD, Cecil Ross, MD, Mamta V Manglani, MD, Guy Young, Tulika Seth, MDMBBS,FAAP, Shashikant Apte, MD FRCPA, Dinesh M Nayak, MD, Maria Elisa Mancuso, Johnny Mahlangu, Bonanad Santiago, MD, Monica H Cerqueira, MD PhD, Nadia P Ewing, MD, Christoph Male, MD, Tarek Owaidah, MDFRCPA, Veronica Soto Arellano, MD, Suvankar Majumdar, MBCHB, Mindy Simpson, MD, Mathew Thomas, MD, Ezio Zanon, Marilyn J Manco-Johnson, MD, Monica Martinez, MD, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Rogelio Alejandro Paredes-Aguilera, MD, Alessandra N L Prezotti, MD MSc, Klaus Schmitt, MD, Bulent Zulfikar, Prof, Pier Mannuccio Mannucci, MD, Frits Richard Rosendaal, MD

Blood (2018) 132 (Supplement 1): 384.

https://doi.org/10.1182/blood-2018-99-114599

Published: 2018

Journal Articles

A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin- 2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy

Mohamed Abd el mohsen, Maha Saber, Amira Adly, Eman Ismail, Omar Elalfy, MD, Elghamry Islam, Fatma Ibrahim, Mohsen Saleh Elalfy, MD

Blood (2018) 132 (Supplement 1): 1058.

https://doi.org/10.1182/blood-2018-99-115186

Published: 2018

Journal Articles

Metabolic Profile & Body Composition in Egyptian Children with Transfusion-Dependent Egyptian B-Thalassemia

Mohsen Saleh Elalfy, MD, Fatma Soliman Elsayed Ebeid, MD MRCPCH, El Gendy Yasmin, MD, Elghamry Islam, MD, Kalifa Amna, MBBCh

Blood (2018) 132 (Supplement 1): 4903.

https://doi.org/10.1182/blood-2018-99-114260

Published: 2018

Journal Articles

Avascular Necrosis of the Femoral Head in Sickle Cell Disease in Egypt and Oman: A Cross Sectional Study

Mohsen Saleh Elalfy, MD, Iman Fadhli, Shaimaa Mohammad, Aida Ali, Naema Shibli, Farah Kindi, Sultan Almaskari, Yasser Wali, MD

Blood (2018) 132 (Supplement 1): 4921.

https://doi.org/10.1182/blood-2018-99-116683

Published: 2018

Journal Articles

The Impact of Cytomegalovirus (CMV) Reactivation on Clinical Course and Immunomodulatory Effect in Children with Immune-Thrombocytopenia (ITP)

Mohsen Saleh Elalfy, MD PhD, Iman Ragab, Marwa Reda, Mohamed Sallam, Hoda Ezz El-Arab, Omneya Shafei, Alaa Mousa

Blood (2017) 130 (Supplement 1): 1045.

https://doi.org/10.1182/blood.V130.Suppl_1.1045.1045

Published: 2017

Journal Articles

A Randomized Trial on the Safety and Efficacy of Early Start of Iron Chelation Therapy with Deferiprone in Newly Diagnosed Children with Transfusion Dependent Thalassemia

Mohsen Saleh Elalfy, MD, Vasilios Berdoukas, MB, BS, Fernando Tricta, MD, Amira Adly, Nyeria Hazza, Hanem Awed, Basma Helal, Mohamed Tarif Salam

Blood (2016) 128 (22): 1286.

https://doi.org/10.1182/blood.V128.22.1286.1286

Published: 2016

Journal Articles

Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study with Genotype - Phenotype Correlation

Mohsen Saleh Elalfy, Amira Adly, Lorena Duca, Tarek Kamal

Blood (2015) 126 (23): 4534.

https://doi.org/10.1182/blood.V126.23.4534.4534

Published: 2015

Journal Articles

Role of Vitamin C As an Adjuvant Therapy with Different Iron Chelators in Young β-Thalassemia Major Patients: Safety and Efficacy in Relation to Tissue Iron Overload

Mohsen Saleh Elalfy, Maha Saber, Amira Adly, Eman Ismail, Mohamed Tarif, Fatma Ibrahim, Omar Elalfy

Blood (2014) 124 (21): 4046.

https://doi.org/10.1182/blood.V124.21.4046.4046

Published: 2014

Journal Articles

Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major

Mohsen Saleh Elalfy, Yasser Wali, MD, FRCPCH, (UK), S Tony, Ahmed Samir, Amira Adly

Blood (2013) 122 (21): 559.

https://doi.org/10.1182/blood.V122.21.559.559

Published: 2013

Journal Articles

Therapeutic Superiority and Safety of Combined Hydroxyurea with Recombinant Human Erythropoietin Over Hydroxyurea in B-Thalassemia Intermedia Patients

Mohsen Saleh Elalfy, Amira Adly, Yassmine Elhanawy

Blood (2012) 120 (21): 252.

https://doi.org/10.1182/blood.V120.21.252.252

Published: 2012

NARROW

Randomized Controlled Trial of the Efficacy and Safety of Deferiprone: Subgroup Analysis of Pediatric Patients in Iron-Overloaded Patients with Sickle Cell Disease and Other Anemias

A Prospective Observational Multicenter Study on Deferiprone & Deferasirox in Clinical Practice of Pediatric Patients with Transfusion-Dependent B-Thalassemia

Safety and Efficacy of Early-Start Deferiprone in Infants and Young Children with Beta-Thalassemia (START study)

A Prospective Randomized Multicenter Trial Using Either Deferiprone or Deferasirox after an Early Start of Deferiprone or Placebo in Young Children Newly Diagnosed with Transfusion-Dependent Beta-Thalassemia

Adolescents and Young Adults with Immune Thrombocytopenia (ITP): A Project of the Carmen-France and Parc-ITP Registry

Brain Iron Content in Egyptian Patients with Sickle Cell Disease: Impact on Neurocognitive Functions

Randomized Controlled Trial of the Efficacy and Safety of Deferiprone in Iron-Overloaded Patients with Sickle Cell Disease or Other Anemias

Intracranial Hemorrhage in Egyptian Children with Primary Immune Thrombocytopenia (ITP): Report of 24 Cases in 20 Years

Pancreatic Iron Deposition Following the Role of Iron Loading Among Transfusion Dependent Sickle Cell Disease Egyptian Children and Young Adults

Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin- 2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy

Metabolic Profile & Body Composition in Egyptian Children with Transfusion-Dependent Egyptian B-Thalassemia

Avascular Necrosis of the Femoral Head in Sickle Cell Disease in Egypt and Oman: A Cross Sectional Study

The Impact of Cytomegalovirus (CMV) Reactivation on Clinical Course and Immunomodulatory Effect in Children with Immune-Thrombocytopenia (ITP)

A Randomized Trial on the Safety and Efficacy of Early Start of Iron Chelation Therapy with Deferiprone in Newly Diagnosed Children with Transfusion Dependent Thalassemia

Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study with Genotype - Phenotype Correlation

Role of Vitamin C As an Adjuvant Therapy with Different Iron Chelators in Young β-Thalassemia Major Patients: Safety and Efficacy in Relation to Tissue Iron Overload

Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major

Therapeutic Superiority and Safety of Combined Hydroxyurea with Recombinant Human Erythropoietin Over Hydroxyurea in B-Thalassemia Intermedia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only